| Net income | 78.5M |
| Depreciation and amortization | 73.8M |
| Equity in earnings of unconsolidated affiliates | -18M |
| Provision for income taxes | 62.1M |
| Income taxes (paid), net of refunds | -40.1M |
| Defined benefit pension expense | |
| Payments under defined benefit pension arrangements | -12.1M |
| Trade accounts receivable | 9.7M |
| Inventories | -5.8M |
| Accounts payable | 11M |
| All other items, net | 69.9M |
| Net cash provided by (used for) operating activities | |
| Capital expenditures | -89.4M |
| Transfer to restricted cash and cash equivalents | |
| Other investing activities | -1.4M |
| Net cash used for investing activities | |
| Repayments under credit arrangements | |
| Proceeds from exercise of stock options | 13.3M |
| Other financing activities | -2.4M |
| Net cash provided by financing activities | |
| Effect of currency exchange rate changes on cash and cash equivalents | |
| Decrease in cash and cash equivalents | 17.9M |
| Cash and cash equivalents, beginning of period | 231.3M |
| Cash and cash equivalents, end of period | 204.4M |